Showing results (81-90 of 127) with videos related to
Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|March 11, 2009
A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinibMichael J Donovan, Angeliki Kotsianti, Valentina Bayer-Zubek, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkDavid R Spigel, John D Hainsworth, Lisa Simons, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junctionDavid R Spigel, F Anthony Greco, Anthony A Meluch, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research ConsortiumDavid R Spigel, John D Hainsworth, Dianna L Shipley, et al.Cancer Investigation|February 18, 2010
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortiumJohn D Hainsworth, Anthony A Meluch, Cassie M Lane, et al.Clinical Advances in Hematology & Oncology : H&O|April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumorsSuzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.Cancer Chemotherapy and Pharmacology|June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabineJeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.Clinical Breast Cancer|November 26, 2009
A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancerDenise A Yardley, Howard A Burris, David R Spigel, et al.The Oncologist|November 25, 2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trialF Anthony Greco, Gladys I Rodriguez, Don W Shaffer, et al.Clinical Colorectal Cancer|August 16, 2011
Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancerDavid R Spigel, Johanna C Bendell, Michael McCleod, et al.Pageof 13